Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress

NEXT STORY
NEOVACS ANNOUNCES THAT THE POSITIVE RESULTS OF ITS PROOF OF CONCEPT IN ALLERGIES WITH IL-4 / IL-13 KINOID HAVE TRIGGERED THE FIRST PAYMENT OF THE ANR GRANT
PREV STORY
Stemline Therapeutics Highlights Recent Clinical and Regulatory Developments and Details Upcoming Milestones following its Annual Shareholder Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Selecta Biosciences Announces Date of First Quarter 2018 Financial Results Conference Call

WATERTOWN, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage ...

author_avatar
NASDAQ Market News

Farm Animal Drugs Market Size to be US$ 23,150 Mn by 2027 at CAGR 6.3%, Says a Research Report By Future Market Insights

Valley Cottage, NY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- The global farm animal drugs ...

author_avatar
NASDAQ Market News

Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2018 RESULTS

PRESS RELEASE: REGULATED INFORMATION Thursday, 6 September 2018, 07:00 CEST BIOCARTIS ANNOUNCES H1 2018 RESULTS ...

author_avatar
NASDAQ Market News